Baxter International
Every day, Baxter touches the lives of millions of patients and providers worldwide who rely on our essential hospital and renal products and services.
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 10 % | 18 % | (2 %) | (28 %) | 7 % | 4 % | 4 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 13 % | 6 % | 12 % | 15 % | 22 % | 22 % | 22 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 10 % | (16 %) | 18 % | (6 %) | 5 % | 6 % | 8 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 4 % | 4 % | 5 % | 6 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Baxter International Inc. is a global healthcare company that provides a broad portfolio of essential medical products and services. The company operates in various segments including critical care, hospital care, nutritional care, renal care, and surgical care. Baxter's products and therapies are integral to hospitals, clinics, and home healthcare settings, addressing the needs of patients from emergency rooms to intensive care units. The company serves healthcare professionals and patients worldwide, focusing on transformative innovation to improve care outcomes and broaden access to healthcare. Baxter's business model revolves around the development, manufacturing, and distribution of medical devices, pharmaceuticals, and biotechnology products. Revenue is generated through the sale of these products and services to healthcare providers, institutions, and patients. The recent acquisition of Hillrom has further strengthened Baxter's position in the healthcare market, enabling the company to offer more comprehensive solutions and improve care efficiencies. Baxter is committed to creating value for its stakeholders through continuous innovation and a patient-centric approach.
Keywords: healthcare, medical devices, pharmaceuticals, biotechnology, critical care, hospital care, renal care, surgical care, innovation, patient-centric.
Tech stack
